The global hyperthermia cancer treatment market size is expected to reach US$265 million by 2030 from US$ 160 millionin 2020, growing at a CAGR of 5.8% from 2021 to 2030.
Hyperthermia is a form of therapy where heat is used to enhance effectiveness of radiation and chemotherapy, and to destroy tumors. Hyperthermia is most often used to treat tumors that are close to the surface of the body. In the hyperthermia treatment, the tumor area is heated to a temperature of 40 degree Celsius to 43 degree Celsius (104 degree Fahrenheit to 109 degree Fahrenheit) for approximately one hour.
Recently, several clinical trials showed that hyperthermia with radiation therapy and/or chemotherapy for the treatment of recurrent breast cancer, melanoma, head & neck cancer, prostate, cervix, and other sites of locally advanced or recurrent cancers provides additional benefits with lower side effects to destroy cancer cells.
Different types of devices used for hyperthermia treatment includes infrared hyperthermia devices, ultrasound hyperthermia devices, microwave hyperthermia devices, and others.
The global hyperthermia cancer treatment market has experienced significant growth in the last decade due to rise in prevalence of various types of cancer and favorable policies.
Rise in prevalence and incidence of cancers such as breast, liver, soft tissue sarcoma, head & neck tumors, prostate cancer, and others drives demand for hyperthermia cancer treatment. According to the National Cancer Institute (NIH), an estimated 1,806,590 cases are expected to be diagnosed in the U.S. in 2020, with prostate, lung, and colorectal cancer likely to account for 43% of the total cancer cases in men. More than 60% of the world’s new cancer cases occur in Africa, Asia, and Central and South America, and 70% of the total cancer deaths globally occur in these regions.
Increase in the geriatric population directly affects the global hyperthermia cancer treatment market. The population aged 65 years and above has higher cancer incidence and mortality rate than younger people. Around 60% of cancer conditions occur among the geriatric population, 10 to 11 times higher than in the younger population.
Deep Tissue Thermal Therapy Holds Promising Potentials in Breast Cancer Treatment
The deep tissue thermal therapy is gaining prominence in the cancer treatment space, especially among patients with breast cancer. The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), U.S., is gaining recognition for its comprehensive and individualized thermal therapy works. This indicates that med-tech companies are unlocking growth opportunities in the U.S., since North America is anticipated to dictate the highest revenue share among all regions in the market. The deep tissue therapy is being combined with the proton therapy to improve medical outcomes.
Ultrasound Hyperthermia Devices Provide Quality Assurance for Treatment of Cancer Patients
The therapeutic application of heat is found to be effective in cancer treatment. Hence, med-tech companies in the hyperthermia cancer treatment market are increasing their production capacities in high quality heating equipment to enable precise thermal dosimetry. This has led to innovations in antennas and power delivery systems that provide adequate quality assurance for the treatment of cancer patients.
High intensity focused ultrasound (HIFU), nanoparticle heating, and scanned focused ultrasound (SFUS) techniques are broadening revenue streams for companies in the hyperthermia cancer treatment market. As such, ultrasound hyperthermia devices are predicted to dominate the second highest revenue among all device types in the market.
In terms of device type, the microwave hyperthermia devices segment is anticipated to grow at a rapid pace during the forecast period, as microwave technique enables heat treatment of tumors, which are deep-seated and/or relatively hard to access in the body. Hence, the preference is high among doctors. This drives the demand for microwave hyperthermia devices in cancer treatment.
Based on treatment method, the locoregional segment held a major share of the global market in 2020, owing to rise in adoption of locoregional method in the treatment of cancer associated with body cavity, organ, or limb, and increase in incidence of lung and prostate cancers.
In terms of application, the increase in incidence of breast cancer is expected to drive the segment during the forecast period. According to the World Health Organization, breast cancer is the most commonly occurring cancer in women and the second most common cancer overall. Over 2 million new cases of breast cancer were diagnosed globally in 2018.
Based on end user, the hospitals & specialty clinics segment dominated the global hyperthermia cancer treatment market in terms of revenue in 2020.
North America dominated the global market in 2020, followed by Europe. North America accounted for a major share of the global hyperthermia cancer treatment market in 2020, attributed to increase in incidence of diseases and new product launches.
The rise in incidence of cancers such as breast and liver and a highly structured healthcare industry fuel the growth of the market in Asia Pacific. According to the World Health Organization, 4,285,033 new cancer cases were diagnosed in China in 2018, with 2,865,174 cancer deaths.
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2017 to 2019.
The analysts have provided a comprehensive analysis of the competitive landscape of the global hyperthermia cancer treatment market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation expected to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users) and other segments.
Key players in the global hyperthermia cancer treatment market include Pyrexar Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.r.l., Yamamoto Vinita Co., Ltd., Chongqing Haifu Medical Technology Co., Ltd., innoMedicus Ltd., Gamida, and RanD.
By Device Type
By Treatment Method
By End User
This report focuses on hyperthermia cancer treatment market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall hyperthermia cancer treatment market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global hyperthermia cancer treatment market.
The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.
In order to understand and assess opportunities in this market, the report is categorically divided into five key sections on the basis of segments. The report analyzes the global market in terms of value (US$ dollers) and volume (Million Units).
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global hyperthermia cancer treatment market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the hyperthermia cancer treatment market.
The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.
In this study, the years considered to estimate the market size of hyperthermia cancer treatment are as follows:
The research methodology adopted by analysts for compiling the global hyperthermia cancer treatment market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global hyperthermia cancer treatment market.
The study objectives of this report are:
Omics-based Clinical Trials Market (By Product: Phase I, Phase II, Phase III, Phase IV; By Study Design: Interventional Studies, Observational Studies, Expanded Access Studies; By Indication : Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases, etc)) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Complementary and Alternative Medicine for Anti Aging & Longevity Market (By Intervention : Traditional Alternative Medicine/Botanicals, Body Healing, Mind Healing, External Energy Healing, Sensory Healing; By Customer: High Net Worth (HNW) Individuals, Very High Net Worth (VHNW) Individuals, Ultra-high Net Worth (UHNW) Individuals) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Defibrillator Market (By Product: Implantable Cardioverter Defibrillators (ICD), External Defibrillators (ED); By End-use: Hospital, Pre Hospital, Public Access Market, Alternate Care Market, Home Healthcare) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Medical Fiber Optics Market (By Fiber Type: Single Mode Optical Fiber, Multimode Optical Fiber; By Application: Endoscopic Imaging, Laser Signal Delivery, Biomedical Sensing, Illumination) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Pharmacovigilance Market (By Service Provider: In-house, Contract Outsourcing; By Product Life Cycle: Pre-clinical, Phase I, Phase II, Phase III, Phase IV; By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining; By Process Flow: Case Data Management, Signal Detection, Risk Management System) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...